Comprehensive study to examine the effects of omalizumab in patients with bronchial asthma.
Phase of Trial: Phase IV
Latest Information Update: 26 Apr 2016
At a glance
- Drugs Omalizumab (Primary)
- Indications Asthma
- Focus Biomarker; Therapeutic Use
- 26 Apr 2016 Results published in the Allergy
- 28 Feb 2012 Planned end date changed from 1 Jul 2012 to 1 Mar 2014 as reported by University Hospital Medical Information Network - Japan record.
- 20 Feb 2012 Additional lead trial investigator (Matsumoto H) identified as reported by University Hospital Medical Information Network - Japan record.